Education
About Us
Working with TipRanks
Follow Us
GeoVax Labs (GOVX)
NASDAQ:GOVX
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 01, 2025
|% Change Since: -2.97%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments in clinical trials and strategic partnerships, juxtaposed with financial challenges and the discontinuation of a significant government contract. While progress in vaccine development is evident, the financial impacts and operational hurdles maintain a level of uncertainty.Company Guidance
During the GeoVax First Quarter 2025 Corporate Update Call, the company provided guidance on various fronts, highlighting key metrics and developments. GeoVax's first-quarter revenue from the BARDA contract was $1.6 million, marking a new revenue stream compared to zero in the previous year. Research and development expenses increased by 21% to $5.4 million, primarily due to costs related to the BARDA contract and ongoing vaccine programs. General and administrative expenses rose 16% to $1.7 million. The company reported a net loss of $5.4 million, or $0.45 per share, an improvement from a $5.9 million loss in 2024. Cash balances were $7.4 million as of March 31, 2025, up from $5.5 million at the end of 2024, due to $7.9 million in financing activities. The update also addressed the unexpected Stop Work Order from BARDA, estimating its financial impact to be less than $750,000 annually. The company remains focused on advancing its vaccine and therapeutic candidates, including GEO-CM04S1, GEO-MVA, and Gedeptin, while exploring strategic partnerships and additional funding opportunities to support its development programs.Robust Vaccine Development Portfolio
GeoVax is progressing with its portfolio, including GEO-CM04S1, GEO-MVA, Gedeptin, and an advanced MVA manufacturing process, addressing unmet healthcare needs and offering expedited registration paths.
GEO-MVA Vaccine Advancements
Completed cGMP production and quality release of GEO-MVA clinical batch, with vaccine availability for clinical evaluation anticipated later in 2025.
Promising Clinical Trials for CM04S1
Ongoing Phase 2 trials for CM04S1, focusing on immunocompromised populations, with expected multiple clinical result presentations throughout 2025.
Increased Revenue from BARDA Contract
Revenue associated with the BARDA contract was $1.6 million in 2025, compared to zero in 2024, marking a significant financial improvement.
Strategic Partnerships and Collaborations
Ongoing discussions with various stakeholders, including WHO, White House, and Congressional Representatives, underscore GeoVax's strategic efforts for global development and commercialization.
---
GOVX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GOVX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 01, 2025 | $1.01 | $0.99 | -1.98% |
Mar 27, 2025 | $1.27 | $1.11 | -12.60% |
Nov 12, 2024 | $3.25 | $2.70 | -16.92% |
Aug 06, 2024 | $1.80 | $1.78 | -1.11% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does GeoVax Labs (GOVX) report earnings?
GeoVax Labs (GOVX) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is GeoVax Labs (GOVX) earnings time?
GeoVax Labs (GOVX) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GOVX EPS forecast?
Currently, no data Available
---